Iht Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Iht Wealth Management, LLC

$3.44 Billion
Q3 2024

A detailed history of Iht Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Iht Wealth Management, LLC holds 2,531 shares of VRTX stock, worth $1.01 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,531

Previous 2,064 22.63%

Holding current value

$1.01 Million

Previous $967,000 21.72%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $214,820 - $236,199	467 Added 22.63%	2,531 $1.18 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $20,033 - $24,762	-51 Reduced 2.41%	2,064 $967,000
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $137,391 - $150,328	337 Added 18.95%	2,115 $884,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $12,348 - $14,784	36 Added 2.07%	1,778 $723,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $20,290 - $21,747	-60 Reduced 3.33%	1,742 $605,000
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $44,333 - $49,619	-141 Reduced 7.26%	1,802 $634,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $19,826 - $22,617	-70 Reduced 3.48%	1,943 $612,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $60,581 - $68,153	-212 Reduced 9.53%	2,013 $581,000
Q3 2022 Nov 22, 2022	BUY	$273.83 - $305.53 $609,271 - $679,804	2,225 New	2,225 $644,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $431,856 - $537,706	-1,838 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $537,607 - $633,635	-2,428 Reduced 56.92%	1,838 $480,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $92,399 - $116,640	-522 Reduced 10.9%	4,266 $937,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $264,648 - $296,162	-1,459 Reduced 23.36%	4,788 $868,000
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $116,056 - $136,860	619 Added 11.0%	6,247 $1.26 Million
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $115,103 - $134,168	556 Added 10.96%	5,628 $1.21 Million
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $502,827 - $670,622	2,429 Added 91.9%	5,072 $1.2 Million
Q3 2020 Nov 19, 2020	SELL	$255.65 - $303.1 $464,516 - $550,732	-1,817 Reduced 40.74%	2,643 $719,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $480,046 - $629,758	2,129 Added 91.33%	4,460 $1.3 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $231,333 - $286,963	1,158 Added 98.72%	2,331 $555,000
Q4 2019 Feb 18, 2020	SELL	$166.71 - $223.91 $36,509 - $49,036	-219 Reduced 15.73%	1,173 $257,000
Q3 2019 Nov 15, 2019	BUY	$166.23 - $187.09 $33,578 - $37,792	202 Added 16.97%	1,392 $236,000
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $195,885 - $226,540	1,190 New	1,190 $218,000
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $17,049 - $19,885	-117 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $10,982 - $12,444	80 Added 216.22%	117 $18,000
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $5,480 - $6,002	37	37 $6,000

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.

Account

Iht Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History